The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Gene fragments are pieces of genes containing only the exons (those parts of the gene which actually encode the protein sequence). They are composed of cDNA. Gene Fragment can be used in CRISPR-Based Genome Editing, Recombinant Antibody Engineering, cloning process, qPCR and PCR Controls, Enzyme Engineering, Vaccine Research, High Resolution Melt (HRM) Assays etc field.
The global Gene Fragment market was valued at US$ 263.8 million in 2023 and is anticipated to reach US$ 566.5 million by 2030, witnessing a CAGR of 11.4% during the forecast period 2024-2030.
Global key players of gene fragment include Integrated DNA Technologies, Thermo Scientific, Eurofins Scientific, GenScript Biotech, Azenta Life Sciences, etc. The top five players hold a share over 70%. North America is the largest market, has a share about 40%, followed by Asia-Pacific, and Europe, with share 29% and 25%, separately.
This report aims to provide a comprehensive presentation of the global market for Gene Fragment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Fragment.
Report Scope
The Gene Fragment market size, estimations, and forecasts are provided in terms of sales volume (Million bp) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Fragment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Fragment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List):
- Integrated DNA Technologies
- Thermo Scientific
- Eurofins Scientific
- GenScript Biotech
- Azenta Life Sciences
- Twist Bioscience
- Synbio Technologies
- Bio Basic
- BiOligo Biotechnology
Segment by Type
- 0-999 bp
- 1000-1999 bp
- 2000-3999 bp
- 4000+ bp
Segment by Application
- CRISPR-based Genome Editing
- Antibody Engineering
- Cloning Process
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gene Fragment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gene Fragment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Gene Fragment Market Overview
1.1 Product Overview and Scope of Gene Fragment
1.2 Gene Fragment Segment by Type
1.2.1 Global Gene Fragment Market Value Comparison by Type (2024-2030)
1.2.2 0-999 bp
1.2.3 1000-1999 bp
1.2.4 2000-3999 bp
1.2.5 4000+ bp
1.3 Gene Fragment Segment by Application
1.3.1 Global Gene Fragment Market Value by Application: (2024-2030)
1.3.2 CRISPR-based Genome Editing
1.3.3 Antibody Engineering
1.3.4 Cloning Process
1.3.5 Others
1.4 Global Gene Fragment Market Size Estimates and Forecasts
1.4.1 Global Gene Fragment Revenue 2019-2030
1.4.2 Global Gene Fragment Sales 2019-2030
1.4.3 Global Gene Fragment Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gene Fragment Market Competition by Manufacturers
2.1 Global Gene Fragment Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gene Fragment Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gene Fragment Average Price by Manufacturers (2019-2024)
2.4 Global Gene Fragment Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gene Fragment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gene Fragment, Product Type & Application
2.7 Gene Fragment Market Competitive Situation and Trends
2.7.1 Gene Fragment Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gene Fragment Players Market Share by Revenue
2.7.3 Global Gene Fragment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gene Fragment Retrospective Market Scenario by Region
3.1 Global Gene Fragment Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gene Fragment Global Gene Fragment Sales by Region: 2019-2030
3.2.1 Global Gene Fragment Sales by Region: 2019-2024
3.2.2 Global Gene Fragment Sales by Region: 2025-2030
3.3 Global Gene Fragment Global Gene Fragment Revenue by Region: 2019-2030
3.3.1 Global Gene Fragment Revenue by Region: 2019-2024
3.3.2 Global Gene Fragment Revenue by Region: 2025-2030
3.4 North America Gene Fragment Market Facts & Figures by Country
3.4.1 North America Gene Fragment Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gene Fragment Sales by Country (2019-2030)
3.4.3 North America Gene Fragment Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gene Fragment Market Facts & Figures by Country
3.5.1 Europe Gene Fragment Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gene Fragment Sales by Country (2019-2030)
3.5.3 Europe Gene Fragment Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gene Fragment Market Facts & Figures by Country
3.6.1 Asia Pacific Gene Fragment Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gene Fragment Sales by Country (2019-2030)
3.6.3 Asia Pacific Gene Fragment Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gene Fragment Market Facts & Figures by Country
3.7.1 Latin America Gene Fragment Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gene Fragment Sales by Country (2019-2030)
3.7.3 Latin America Gene Fragment Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gene Fragment Market Facts & Figures by Country
3.8.1 Middle East and Africa Gene Fragment Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gene Fragment Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gene Fragment Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gene Fragment Sales by Type (2019-2030)
4.1.1 Global Gene Fragment Sales by Type (2019-2024)
4.1.2 Global Gene Fragment Sales by Type (2025-2030)
4.1.3 Global Gene Fragment Sales Market Share by Type (2019-2030)
4.2 Global Gene Fragment Revenue by Type (2019-2030)
4.2.1 Global Gene Fragment Revenue by Type (2019-2024)
4.2.2 Global Gene Fragment Revenue by Type (2025-2030)
4.2.3 Global Gene Fragment Revenue Market Share by Type (2019-2030)
4.3 Global Gene Fragment Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gene Fragment Sales by Application (2019-2030)
5.1.1 Global Gene Fragment Sales by Application (2019-2024)
5.1.2 Global Gene Fragment Sales by Application (2025-2030)
5.1.3 Global Gene Fragment Sales Market Share by Application (2019-2030)
5.2 Global Gene Fragment Revenue by Application (2019-2030)
5.2.1 Global Gene Fragment Revenue by Application (2019-2024)
5.2.2 Global Gene Fragment Revenue by Application (2025-2030)
5.2.3 Global Gene Fragment Revenue Market Share by Application (2019-2030)
5.3 Global Gene Fragment Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Integrated DNA Technologies
6.1.1 Integrated DNA Technologies Corporation Information
6.1.2 Integrated DNA Technologies Description and Business Overview
6.1.3 Integrated DNA Technologies Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Integrated DNA Technologies Gene Fragment Product Portfolio
6.1.5 Integrated DNA Technologies Recent Developments/Updates
6.2 Thermo Scientific
6.2.1 Thermo Scientific Corporation Information
6.2.2 Thermo Scientific Description and Business Overview
6.2.3 Thermo Scientific Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Thermo Scientific Gene Fragment Product Portfolio
6.2.5 Thermo Scientific Recent Developments/Updates
6.3 Eurofins Scientific
6.3.1 Eurofins Scientific Corporation Information
6.3.2 Eurofins Scientific Description and Business Overview
6.3.3 Eurofins Scientific Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eurofins Scientific Gene Fragment Product Portfolio
6.3.5 Eurofins Scientific Recent Developments/Updates
6.4 GenScript Biotech
6.4.1 GenScript Biotech Corporation Information
6.4.2 GenScript Biotech Description and Business Overview
6.4.3 GenScript Biotech Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GenScript Biotech Gene Fragment Product Portfolio
6.4.5 GenScript Biotech Recent Developments/Updates
6.5 Azenta Life Sciences
6.5.1 Azenta Life Sciences Corporation Information
6.5.2 Azenta Life Sciences Description and Business Overview
6.5.3 Azenta Life Sciences Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Azenta Life Sciences Gene Fragment Product Portfolio
6.5.5 Azenta Life Sciences Recent Developments/Updates
6.6 Twist Bioscience
6.6.1 Twist Bioscience Corporation Information
6.6.2 Twist Bioscience Description and Business Overview
6.6.3 Twist Bioscience Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Twist Bioscience Gene Fragment Product Portfolio
6.6.5 Twist Bioscience Recent Developments/Updates
6.7 Synbio Technologies
6.6.1 Synbio Technologies Corporation Information
6.6.2 Synbio Technologies Description and Business Overview
6.6.3 Synbio Technologies Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Synbio Technologies Gene Fragment Product Portfolio
6.7.5 Synbio Technologies Recent Developments/Updates
6.8 Bio Basic
6.8.1 Bio Basic Corporation Information
6.8.2 Bio Basic Description and Business Overview
6.8.3 Bio Basic Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bio Basic Gene Fragment Product Portfolio
6.8.5 Bio Basic Recent Developments/Updates
6.9 BiOligo Biotechnology
6.9.1 BiOligo Biotechnology Corporation Information
6.9.2 BiOligo Biotechnology Description and Business Overview
6.9.3 BiOligo Biotechnology Gene Fragment Sales, Revenue and Gross Margin (2019-2024)
6.9.4 BiOligo Biotechnology Gene Fragment Product Portfolio
6.9.5 BiOligo Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gene Fragment Industry Chain Analysis
7.2 Gene Fragment Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gene Fragment Production Mode & Process
7.4 Gene Fragment Sales and Marketing
7.4.1 Gene Fragment Sales Channels
7.4.2 Gene Fragment Distributors
7.5 Gene Fragment Customers
8 Gene Fragment Market Dynamics
8.1 Gene Fragment Industry Trends
8.2 Gene Fragment Market Drivers
8.3 Gene Fragment Market Challenges
8.4 Gene Fragment Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
